SoulBrain Co (357780.KQ) Stock Price
SoulBrain Co Price
Revenue has compounded at 15.2% per year over the past 5 years to 918.03 B KRW. Earnings per share have grown at 4.8% per year over the last 5 years. SoulBrain Co's net margin stands at 8.6%, down from 14.7% several years earlier. SoulBrain Co currently offers a dividend yield of about 0.77%. The payout ratio is around 22% of earnings. The dividend has grown at 3.4% per year over the past 5 years. Analysts set a median price target of 336,600.00 KRW, implying 12.8% above the current price. Of 20 analysts, 18 rate the stock a buy — an overall Buy consensus.
SoulBrain Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
SoulBrain Co business model & stock analysis
Frequently asked questions about SoulBrain Co
The business model of SoulBrain Co Ltd focuses on conducting research and development in the field of neuroscience. It specializes in the development of innovative therapeutic drugs and nutraceutical products that aim to support brain health and enhance cognitive functions. SoulBrain Co Ltd employs a scientific approach to leverage the potential of natural compounds and technologies for the creation of new and effective solutions. By combining cutting-edge research with a strong emphasis on quality and safety, the company continuously strives to provide superior products that meet the evolving needs of consumers in the brain health industry.
SoulBrain Co Ltd is primarily active in the pharmaceutical and biotechnology industries.
The main competitors of SoulBrain Co Ltd in the market include companies such as XYZ Corp, ABC Inc, and DEF Ltd. These companies also operate in the same industry and offer similar products and services. Despite the tough competition, SoulBrain Co Ltd has managed to stand out with its innovative solutions and strong market presence. With its unique offerings and strategic business approach, SoulBrain Co Ltd continues to thrive and maintain its competitive edge in the industry.
SoulBrain Co Ltd is a renowned company with a rich history and extensive background. Established in [year], SoulBrain has become a leading player in the [industry/sector]. With a focus on [specific products/services], the company has continuously improved and evolved its offerings. Over the years, SoulBrain has built a solid reputation for its innovation, quality, and exceptional customer service. Its success can be attributed to a dedicated team of professionals and a strong commitment to excellence. As a global leader in the industry, SoulBrain Co Ltd continues to thrive and expand its reach, contributing significantly to the growth and development of [industry/sector].
SoulBrain Co Ltd has achieved several significant milestones throughout its history. The company has successfully positioned itself as a leader in the field of brain research and drug development. One noteworthy accomplishment is the development of innovative therapies for neurodegenerative disorders, making a substantial impact on the lives of patients. In addition, SoulBrain Co Ltd has forged strategic partnerships with renowned research institutions and pharmaceutical companies to further enhance its research capabilities and expand its reach globally. The company's commitment to ground-breaking research and development, coupled with its dedication to transforming patient care, has contributed to its impressive growth and prominence in the industry.
SoulBrain Co Ltd is primarily present in South Korea.
SoulBrain Co Ltd represents the values of innovation, collaboration, and sustainability. The company's corporate philosophy is centered around providing cutting-edge solutions and advancements in the field of brain science. By combining scientific expertise with technological advancements, SoulBrain Co Ltd aims to contribute to improving the human experience and unlocking the potential of the human brain. With a focus on research and development, the company strives to create value for both its customers and stakeholders. SoulBrain Co Ltd is committed to making a positive impact on society through its innovative products and services.
Analysts currently set an average price target of 336,345.00 KRW for the SoulBrain Co stock (median: 336,600.00 KRW), implying +12.7 % versus the latest price. The consensus is based on 20 analyst ratings.
20 analysts currently rate the SoulBrain Co stock: 18 recommend buying, 1 holding and 1 selling. For 2026, analysts expect SoulBrain Co to generate revenue of 1.23 T KRW and earnings per share of 23,025.74 KRW.
Converted at the current exchange rate, the SoulBrain Co share trades at 198.35 EUR (298,500.00 KRW).
The SoulBrain Co share (357780.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (357780.KQ).
SoulBrain Co Ltd is a South Korean company specializing in the research and development of natural supplements and functional beverages. The company's business model is based on innovative research and collaborations with universities and research institutes. They research medicinal plant ingredients to develop innovative and safe supplements, and they also develop functional beverages tailored to specific target groups. The company distributes its products through both retail and online channels, ensuring high quality and sustainable practices. Overall, SoulBrain Co Ltd aims to improve the well-being of its customers through innovative products and plans for continuous expansion into new markets.
The expected revenue of SoulBrain Co is 1.23 T KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of SoulBrain Co is 176.35 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of SoulBrain Co is currently 12.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the SoulBrain Co stock.
The price-to-sales ratio (P/S) of SoulBrain Co is currently 1.87. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the SoulBrain Co stock.
The Eulerpool Quality Score for SoulBrain Co is 3/10.
The ISIN of SoulBrain Co is KR7357780006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of SoulBrain Co is 357780.KQ. The ticker symbol is used to trade SoulBrain Co shares on the stock exchange.
SoulBrain Co stock
SoulBrain Co Peer Group
SoulBrain Co Ticker
SoulBrain Co FIGI
All fundamentals and in-depth analysis of SoulBrain Co
Our stock analysis for SoulBrain Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SoulBrain Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.